When we look at how much money they make before expenses, they keep 0.257% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.270%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.036%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.030% return, is a testament to Igene Biotechnology, Inc.'s adeptness in optimizing resource deployment. Igene Biotechnology, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.052%. Furthermore, the proficiency of Igene Biotechnology, Inc. in capital utilization is underscored by a remarkable -0.334% return on capital employed.
Stock Prices
Igene Biotechnology, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.00001, while its low point bottomed out at $0.00001. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Igene Biotechnology, Inc.'s stock market.
Liquidity Ratios
Analyzing IGNE liquidity ratios reveals its financial health of the firm.
The current ratio of 234.61% gauges short-term asset coverage for liabilities.
The quick ratio (231.76%) assesses immediate liquidity, while the cash ratio (83.03%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
234.61%
Quick Ratio
231.76%
Cash Ratio
83.03%
Profitability Ratios
IGNE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -1.09% underscores its earnings before tax deductions.
The effective tax rate stands at -382.58%, revealing its tax efficiency.
The net income per EBT, 325.60%, and the EBT per EBIT, 4.04%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -27.03%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-1.09%
Effective Tax Rate
-382.58%
Net Income per EBT
325.60%
EBT per EBIT
4.04%
EBIT per Revenue
-27.03%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 2.35, it details the span from stock purchase to revenue.
The 2 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 170.60% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
232
Operating Cycle
213.95
Cash Conversion Cycle
214
Receivables Turnover
1.71
Fixed Asset Turnover
4.64
Asset Turnover
0.83
Cash Flow Ratios
Lastly, the operating cash flow sales ratio, -0.02, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow Sales Ratio
-0.02
Free Cash Flow to Operating Cash Flow Ratio
2.77
Cash Flow Coverage Ratio
-0.01
Short Term Coverage Ratio
-0.09
Capital Expenditure Coverage Ratio
-0.56
Dividend Paid and Capex Coverage Ratio
-0.56
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 142.79%, highlights its total liabilities relative to assets.
With a debt-equity ratio of -2.48, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 192.67%, and total debt to capitalization, 167.65%, ratios shed light on its capital structure.
An interest coverage of -10.97 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
142.79%
Debt Equity Ratio
-2.48
Long Term Debt to Capitalization
192.67%
Total Debt to Capitalization
167.65%
Interest Coverage
-10.97
Cash Flow to Debt Ratio
-0.01
Company Equity Multiplier
-1.74
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -48.23%, indicates top-line expansion, while the gross profit growth, -18.72%, reveals profitability trends.
EBIT growth, 51.11%, and operating income growth, 51.11%, offer insights into operational profitability progression.
The net income growth, 96.47%, showcases bottom-line expansion, and the EPS growth, 99.53%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-48.23%
Gross Profit Growth
-18.72%
EBIT Growth
51.11%
Operating Income Growth
51.11%
Net Income Growth
96.47%
EPS Growth
99.53%
EPS Diluted Growth
99.53%
Weighted Average Shares Growth
722.18%
Weighted Average Shares Diluted Growth
722.18%
Operating Cash Flow Growth
-113.75%
Free Cash Flow Growth
-156.07%
10-Year Revenue Growth per Share
382.35%
10-Year Operating CF Growth per Share
99.87%
5-Year Operating CF Growth per Share
-6940.27%
3-Year Operating CF Growth per Share
-6940.27%
10-Year Net Income Growth per Share
99.88%
5-Year Net Income Growth per Share
99.14%
3-Year Net Income Growth per Share
99.14%
10-Year Shareholders Equity Growth per Share
99.12%
5-Year Shareholders Equity Growth per Share
98.82%
3-Year Shareholders Equity Growth per Share
98.82%
Receivables Growth
121.85%
Inventory Growth
-100.00%
Asset Growth
-21.53%
Book Value per Share Growth
87.54%
Debt Growth
26.95%
R&D Expense Growth
11.79%
SGA Expenses Growth
-31.19%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 20,879,108.3, captures the company's total value, considering both debt and equity.
Income quality, 0.69, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.21, gauges operational efficiency, while the research and development to revenue, 46.77%, highlights investment in innovation.
The ratio of intangibles to total assets, 3.14%, indicates the value of non-physical assets, and capex to operating cash flow, 177.00%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
20,879,108.3
Income Quality
0.69
Sales General and Administrative to Revenue
0.21
Research and Development to Revenue
46.77%
Intangibles to Total Assets
3.14%
Capex to Operating Cash Flow
177.00%
Capex to Revenue
-4.34%
Capex to Depreciation
-113.97%
Return on Tangible Assets
-3.05%
Working Capital
2,099,781
Tangible Asset Value
-2,892,241
Net Current Asset Value
-3,842,646
Invested Capital
-2
Average Receivables
1,682,890.5
Average Inventory
1,199,260
Days Sales Outstanding
214
ROIC
-127.36%
ROE
0.05%
Valuation Ratios
The price to sales ratio, 0.03, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -0.41, and price to operating cash flows, -0.02, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price to Sales Ratio
0.03
Price Cash Flow Ratio
-0.02
Enterprise Value Multiple
6.33
Price to Operating Cash Flow Ratio
-0.02
Price to Free Cash Flows Ratio
-0.41
Price to Tangible Book Ratio
-5.61
Enterprise Value to Sales
5.28
Enterprise Value Over EBITDA
-24.53
EV to Operating Cash Flow
-215.14
Earnings Yield
-0.92%
Free Cash Flow Yield
-1.75%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
